Andreas Burchert

Andreas Burchert

MD, PhD

Academic history

Andreas Burchert, MD, PhD, is the Deputy Clinical Director and a Senior Physician at the Philipps-University Marburg, Marburg, Germany.

Speaking on novel therapies for AML

Prof. Burchert’s primary research focus is on novel therapies for the treatment of acute myeloid leukemia (AML). In particular, Prof. Burchert has recently worked on a study investigating whether FLT3-ITD inhibition with sorafenib can prevent AML relapse.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter